[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487770":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":28,"responsibleParty":58,"collaborators":11,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":11,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":11,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":30,"whyStopped":11,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR",null,[13],"Drug: Placebo",{"label":15,"type":16,"description":11,"interventionNames":17},"Intervention","EXPERIMENTAL",[18],"Drug: Dexamethasone",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","Dexamethasone","Patients treated with dexamethasone",[15],{"type":21,"name":9,"description":26,"armGroupLabels":27,"otherNames":11},"Patients treated with placebo",[9],[29,47],{"facility":5,"status":30,"city":31,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Bangkok","Thailand","TH",{"type":35,"coordinates":36},"Point",[37,38],100.50144,13.75398,{"lat":38,"lon":37},[41],{"name":42,"role":43,"phone":44,"phoneExt":45,"email":46},"Nattachai Srisawat","CONTACT","02-256-4000","3597","drnattachai@yahoo.com",{"facility":48,"status":30,"city":31,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":49,"geoPoint":51,"contacts":52},"King Chulalongkorn Memorial Hospital",{"type":35,"coordinates":50},[37,38],{"lat":38,"lon":37},[53],{"name":54,"role":43,"phone":55,"phoneExt":56,"email":57},"Sasipha Tachaboon","6622564000","3679","sasipha_tac@hotmail.com",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Nattachai Srisawat ,M.D.","Principal investigator","100487770","efficacy-of-dengue-infection-with-warning-signs-treated-with-dexamethasone-dengdex-study-100487770",false,"NCT05631405","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone","Inclusion Criteria:\n\n* Laboratory confirmed Dengue infected patients (Positive NS1 Ag or anti-DENV IgM by Dengue Duo test)\n* And still in febrile phase (Body temp\\>37.5 C)\n* Shock : Sys\\\u003C90mmHg or Narrow PP (\\\u003C20mmHg) orTachycardia (pulse\\>100\u002Fmin) with Hematocrit decreased ≥20 %\n* Fluid accumulation and respiratory distress\n* Severe bleeding\n* Severe organ involvement\n\nExclusion Criteria:\n\n* Severe dengue\\> 24 hrs\n* Dengue without warning signs\n* Pregnancy\n* Patient who receieved any steroid within 1 week","ALL","7 Years","99 Years",{"count":73,"type":74},200,"ESTIMATED","INTERVENTIONAL",[77],"NA","The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.",[80],"Severe Dengue",[80,22,82],"Steroid","2026-06-15",{"date":85,"type":86},"2026-06-16","ACTUAL",{"date":88,"type":86},"2022-10-16",{"date":90,"type":74},"2027-12-31",{"name":5,"class":6},2]